Content area
Full Text
LATEST COMPANY NEWS
News and Commentary
Innovating healthcare for tech edge - 25/9/2017
Carestream Health's VP Liu Jie leads his team's efforts to help modernize China's medical services.
For the complete story see:
http://www.chinadaily.com.cn/bizchina/2017-09/25/content_32447314.htm
FierceBiotech - China's WuXi, Johnson & Johnson-backed XW Labs lands $17.5M series B - 20/9/2017
Chinese neurological disorders startup XW Laboratories has seen a $17.5 million series B, bumping up its total raise from its first round to $23 million.
For the complete story see:
http://www.fiercebiotech.com/biotech/china-s-wuxi-j-j-backed-xw-labs-lands-17-5m-series-b
Caixin Global - Drugmaker Bets Big on Biopharma - 20/9/2017
A Chinese drugmaker plans to issue more than 1 billion yuan ($151.85 million) in bonds to build a new biopharmaceutical industrial park in the eastern city of Hangzhou.
For the complete story see:
http://www.caixinglobal.com/2017-09-20/101147922.html
Reuters - China's drugmakers boast Big Pharma option value- 18/9/2017
China's drug companies could provide a boost to Big Pharma.
For the complete story see:
https://www.reuters.com/article/us-china-biotech-breakingviews/breakingviews-chinas-drugmakers-boast-big-pharma-option-value-idUSKCN1BT086
South China Morning Post - China's Fosun Pharma to bypass India's regulatory hurdles after cutting stake in Gland Pharma deal - 18/9/2017
Chinese drug maker to cut the stake it wants to buy in India's Gland Pharma to ensure faster regulatory approvals
For the complete story see:
http://www.scmp.com/business/china-business/article/2111631/chinas-fosun-pharma-bypass-indias-regulatory-hurdles-after
https://www.facebook.com/acquisdata/
https://twitter.com/acquisdata
Media Releases
Shanghai Pharma (SHA: 601607) - Shanghai Pharma Tops the Asian Pharmaceutical Industry in Brand Value - 22/9/2017
The 12th Asia Brand Ceremony, jointly held by Asia Brand, China-Asia Economic Development Association (administrated by Ministry of Foreign Affairs), Hong Kong Ta Kung Wen Wei Media Group, and the daily paper of "International Business" (founded by Ministry of Commerce), was held in Hong Kong recently, in which the "Top 500 Asia Brands 2017" was announced. Among the listed pharmaceutical brands, Shanghai Pharma ranked first with a brand value of 45,161 million yuan.
The Top 500 Asia Brands spread over 15 countries and regions. China (including Hong Kong, Macao and Taiwan) ranked top with 280 brands, accounting for 56% of all the 500 brands; Japan ranked the second with 130 brands, accounting for 26%; the third was South Korea, with 23 brands; India and Singapore followed with 21 and 17 brands respectively. According to the industry distribution, the list involves a total of 39 industries, and 16 pharmaceutical brands on the list of "Top 500 Asia...